Showing results (281-290 of 295) with videos related to
Sort By:
Pageof 30
Cancer Research|July 29, 2021
Long Noncoding RNA NIHCOLE Promotes Ligation Efficiency of DNA Double-Strand Breaks in Hepatocellular CarcinomaJuan P Unfried, Mikel Marín-Baquero, Ángel Rivera-Calzada, et al.Chemmedchem|March 29, 2023
Optimization of a Class of Dihydrobenzofurane Analogs toward Orally Efficacious YAP-TEAD Protein-Protein Interaction InhibitorsHolger Sellner, Emilie Chapeau, Pascal Furet, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 12, 2010
Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out miceYing Gao, Dmitry V Vasilyev, Maria Beatriz Goncalves, et al.Frontiers in Psychiatry|April 10, 2023
A systematic scoping review on the evidence behind debriefing practices for the wellbeing/emotional outcomes of healthcare workersThomas Rhys Evans, Calvin Burns, Ryan Essex, et al.ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of AsthmaDavid A Sandham, Lucy Barker, Lyndon Brown, et al.ACS Medicinal Chemistry Letters|September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma"David A Sandham, Lucy Barker, Lyndon Brown, et al.International Journal of Cardiology|June 18, 2022
Validation of time-resolved, automated peak trans-mitral velocity tracking: Two center four-dimensional flow cardiovascular magnetic resonance studyPaul Njoku, Ciaran Grafton-Clarke, Hosamadin Assadi, et al.Bioorganic & Medicinal Chemistry Letters|May 29, 2007
2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonistsDavid A Sandham, Clive Aldcroft, Urs Baettig, et al.Bioorganic & Medicinal Chemistry|September 12, 2013
Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseasesDavid A Sandham, Nicola Arnold, Heinrich Aschauer, et al.Journal of Medicinal Chemistry|March 17, 2021
Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus FusionG Stuart Cockerill, Richard M Angell, Alexandre Bedernjak, et al.Pageof 30